Targeted treatments work by identifying and attacking specific molecular targets associated with disease. The process often involves the use of monoclonal antibodies or small-molecule inhibitors that can bind to these targets and inhibit their function. For instance, in cancer therapy, targeted treatments may block the activity of proteins that promote tumor growth and survival.
